Valvular heart disease in pregnancy

New England Journal of Medicine

Volumn 349, Issue 1, 2003, Pages 52-59

  Reimold, Sharon C ^a   Rutherford, John D ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE; AMIODARONE; AMPICILLIN; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GENTAMICIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; METHYLDOPA; NITRATE; QUINIDINE; VANCOMYCIN; VASODILATOR AGENT;

ADULT; ANTIBIOTIC THERAPY; ANTICOAGULATION; AORTA STENOSIS; AORTA VALVE REGURGITATION; BLEEDING; BRADYCARDIA; CASE REPORT; CLINICAL FEATURE; DEVELOPMENTAL DISORDER; DISEASE CLASSIFICATION; DRUG INDICATION; EMBOLISM; ENDOCARDITIS; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VALVE PROSTHESIS; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FUNCTION; HUMAN; HYPERTENSION; HYPOTHYROIDISM; INTRAUTERINE GROWTH RETARDATION; MITRAL VALVE PROSTHESIS; MITRAL VALVE STENOSIS; PRACTICE GUIDELINE; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; REVIEW; UROGENITAL TRACT DISEASE; VALVULAR HEART DISEASE; AORTA VALVE STENOSIS; MITRAL VALVE REGURGITATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; RISK FACTOR;

ADULT; ANTICOAGULANTS; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; FEMALE; HEART VALVE PROSTHESIS; HUMANS; MITRAL VALVE INSUFFICIENCY; MITRAL VALVE STENOSIS; PRACTICE GUIDELINES; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; RISK FACTORS;

EID: 0038506457     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMcp021265     Document Type: Review

References (48)

1. Van Oppen ACA, Van Der Tweel I, Alsbach GPJ, Heethaar RM, Bruinse HW. A longitudinal study of maternal hemodynamics during normal pregnancy. Obstet Gynecol 1996;88:40-6.
2. Mishra M, Chambers JB, Jakson G. Murmurs in pregnancy: an audit of echocardiography. BMJ 1992;304:1413-4.
3. Campos O, Andrade JL, Bocanegra J, et al. Physiologic multivalvular regurgitation during pregnancy: a longitudinal Doppler echocardiographic study. Int J Cardiol 1993;40:265-72.
4. Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001;104:515-21.
5. Siu SC, Colman JM, Sorensen S, et al. Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation 2002;105:2179-84.
6. ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Am Coll Cardiol 1998;32:1486-588. (Also available at http://www.acc.org/clinical/guidelines/valvular/dirIndex.htm.)
7. Hameed A, Karaalp IS, Tummala PP, et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol 2001;37:893-9.
8. Lao T, Sermer M, MaGee L, Farine D, Colman JM. Congenital aortic stenosis and pregnancy - a reappraisal. Am J Obstet Gynecol 1993;169:540-5.
9. Elkayam U, Gleicher N. Cardiac problems in pregnancy: diagnosis and management of maternal and fetal disease. New York: Wiley-Liss, 1998.
10. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. Baltimore: Williams & Wilkins, 1998:xxii.
11. Sugrue D, Troy P, McDonald D. Antibiotic prophylaxis against infective endocarditis after normal delivery - is it necessary? Br Heart J 1980;44:499-502.
12. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 1997;277:1794-801.
13. Clark S. Cardiac disease in pregnancy. Crit Care Clin 1991;7:777-97.
14. Barbosa P, Lopes A, Feotpsa G, et al. Prognostic factors of rheumatic mitral stenosis during pregnancy and puerperium. Arq Bras Cardiol 2000;75:220-24.
15. Brady K, Duff P. Rheumatic heart disease in pregnancy. Clin Obstet Gynecol 1989;32:21-40.
16. Ashcom TL, Johns JP, Bailey SR. Pubal BJ. Effects of chronic beta-blockade on rest and exercise hemodynamics in mitral stenosis. Cathet Cardiovasc Diagn 1995;35:110-5.
17. Stoll BC, Ashcom TL, Johns JP, Johnson JE, Rubal BJ. Effects of atenolol on rest and exercise hemodynamics in patients with mitral stenosis. Am J Cardiol 1995;75:482-4.
18. al Kasab SM, Sabag T, al Zaibag M, et al. B-Adrenergic receptor blockade in the management of pregnant women with mitral stenosis. Am J Obstet Gynecol 1990;163:37-40.
19. Allen NM, Page RL. Procainamide administration during pregnancy. Clin Pharm 1993;12:58-60.
20. Chow T, Galvin J, McGovern B. Antiarrhythmic drug therapy in pregnancy and lactation. Am J Cardiol 1998;82:58-I-62-I.
21. Joglar JA, Page RL. Treatment of cardiac arrhythmias during pregnancy: safety considerations. Drug Saf 1999;20:85-94.
22. Chan WS. What is the optimal management of pregnant women with valvular heart disease in pregnancy? Haemostasis 1999;29: Suppl S1:105-6.
23. Robin F, Lecuru F, Desfeux P, Boucaya V, Taurelle R, Anticoagulant therapy in pregnancy. Eur J Obstet Gynecol Reprod Biol 1999;83:171-7.
24. Stephen SJ. Changing patterns of mitral stenosis in childhood and pregnancy in Sri Lanka. J Am Coll Cardiol 1992;19:1276-84.
25. Fawzy ME, Kinsara AJ, Stefadouros M, et al. Long-term outcome of mitral balloon valvotomy in pregnant women. J Heart Valve Dis 2001;10:153-7.
26. Dekaban A. Abnormalities in children exposed to x-radiation during various stages of gestation: tentative timetable of radiation injury to the human fetus. J Nucl Med 1968;9:471-7.
27. Bernal JM, Miralles PI. Cardiac surgery with cardiopulmonary bypass during pregnancy. Obstet Gynecol Surv 1986;41:1-6.
28. Clark SL, Phelan JP, Greenspoon J, Aldahl D, Horenstein J. Labor and delivery in the presence of mitral stenosis: central hemodynamic observations. Am J Obstet Gynecol 1985;152:984-8.
29. Otto CM. Evaluation and management of chronic mitral regurgitation. N Engl J Med 2001;345:740-6.
30. Enriquez-Sarano M, Schaff HV, Orszulak TA, Tajik AJ, Bailey KR, Frye RL. Valve repair improves the outcome of surgery for mitral regurgitation: a multivariate analysis. Circulation 1995;91:1022-8.
31. Tribouilloy CM, Enriquez-Sarano M, Schaff HV, etal. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. Circulation 1999;99:400-5.
32. Carabello BA. Evaluation and management of patients with aortic stenosis. Circulation 2002;105:1746-50.
33. Parry AJ, Westaby S. Cardiopulmonary bypass during pregnancy. Ann Thorac Surg 1996;61:1865-9.
34. Sullivan HJ. Valvular heart surgery during pregnancy. Surg Clin North Am 1995;75:59-75.
35. Nightingale SL. Warnings on use of ACE inhibitors in the second and third trimester of pregnancy. JAMA 1992;267:2445.
36. Rosenblum NG, Grossman AR, Gabbe SG, Mennuti MT, Cohen AW. Failure of serial echocardiographic studies to predict aortic dissection in a pregnant patient with Marfan's syndrome. Am J Obstet Gynecol 1983;146:470-1.
37. North RA, Sadler L, Stewart AW, McCowan LM, Kerr AR, White HD. Long-term survival and valve-related complications in young women with cardiac valve replacements. Circulation 1999;99:2669-76.
38. Jamieson WR, Miller DC, Akins CW, et al. Pregnancy and bioprostheses: influence on structural valve deterioration. Ann Thorac Surg 1995;60:Suppl:S282-S287.
39. Salazar E, Espinola N, Roman L, Casanova JM. Effect of pregnancy on the duration of bovine pericardial bioprostheses. Am Heart J 1999;137:714-20.
40. Guyatt G, Schunemann H, Cook D, Jaeschke R, Pauker S, Bucher H. Grades of recommendation for antithrombotic agents. Chest 2001;119:Suppl:3S-7S.
41. Gohlke-Barwolf C, Acar J, Oakley C, et al. Guidelines for prevention of thromboembolic events in valvular heart disease. Eur Heart J 1995;16:1320-30.
42. Ginsberg JS, Greer I, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 2001;119:Suppl:122S-131S.
43. Laurent P, Dussarat G, Bonal J, et al. Low molecular weight heparins: A guide to their optimum use in pregnancy. Drugs 2002;62:463-77. [Erratum, Drugs 2002;62:1314.]
44. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intem Med 2000;160:191-6.
45. Sadler L, McCowan L, White H, Stewart A, Bracken M, North R, Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves. BJOG 2000;107:245-53.
46. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995;332:1330-5.
47. Barbour LA, Kick SD, Steiner JF, et al. A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry. Am J Obstet Gynecol 1994;170:862-9.
48. Sanson BJ, Lensing AW, Prins MH, et al. Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thromb Haemost 1999;81:668-72.